Cargando…
Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant?
Autores principales: | Luna, Carlos M., Perín, María M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475410/ https://www.ncbi.nlm.nih.gov/pubmed/32953711 http://dx.doi.org/10.21037/atm-2020-34 |
Ejemplares similares
-
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)
por: Liam, Christopher Chin Keong, et al.
Publicado: (2023) -
Diagnostic performance of lactate dehydrogenase (LDH) isoenzymes levels for the severity of COVID-19
por: Ergenc, Ilkay, et al.
Publicado: (2023) -
Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia
por: Wu, Mei-ying, et al.
Publicado: (2020) -
Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19
por: Li, Chang, et al.
Publicado: (2020) -
Evaluation of lactate dehydrogenase (LDH) in predicting the severity of lung involvement and pneumomediastinum in hospitalized COVID-19
por: Eid, Hind, et al.
Publicado: (2022)